Evidence map›Paper›PMID 32807240›Full record

ArticleAntimicrobial resistance and infection control2020

A rapid model for developing dry surface biofilms of Staphylococcus aureus and Pseudomonas aeruginosa for in vitro disinfectant efficacy testing.

Carine A Nkemngong, Maxwell G Voorn, Xiaobao Li, Peter J Teska, Haley F Oliver

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. How biofilm changes our understanding of cleaning and disinfection.Antimicrobial resistance and infection control · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Cold Atmospheric Pressure Plasma Device Exhibits Etching Effects on Bacterial Biofilms.IEEE transactions on radiation and plasma medical sciences · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carine A NkemngongDepartment of Food Science, Purdue University, 745 Agriculture Mall Drive, West Lafayette, IN, 47907, USA.
Maxwell G VoornDepartment of Food Science, Purdue University, 745 Agriculture Mall Drive, West Lafayette, IN, 47907, USA.
Xiaobao LiDiversey Inc., Charlotte, NC, 28273, USA.
Peter J TeskaDiversey Inc., Charlotte, NC, 28273, USA.
Haley F OliverDepartment of Food Science, Purdue University, 745 Agriculture Mall Drive, West Lafayette, IN, 47907, USA. hfoliver@purdue.edu.ORCID 0000-0002-5851-6523

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBacterial biofilms persistent on dry environmental surfaces in healthcare facilities play an important role in the occurrence of healthcare associated infections (HAI). Compared to wet surface biofilms and planktonic bacteria, dry surface biofilms (DSB) are more tolerant to disinfection. However, there is no official method for developing DSB for in vitro disinfectant efficacy testing. The objectives of this study were to (i) develop an in vitro model of DSB of S. aureus and P. aeruginosa for disinfectant efficacy testing and (ii) investigate the effect of drying times and temperatures on DSB development. We hypothesized that a minimum six log

methodsS. aureus ATCC-6538 and P. aeruginosa ATCC-15442 wet surface biofilms were grown on glass coupons following EPA MLB SOP MB-19. A DSB model was developed by drying coupons in an incubator and viable bacteria were recovered following a modified version of EPA MLB SOP MB-20. Scanning electron microscopy was used to confirm the EPS presence on DSB.

resultsOverall, a minimum of six mean log

conclusionA rapid model for developing DSB with characteristic EPS was developed for disinfectant efficacy testing against DSB.

Indexed as

BiofilmsDisinfectantsDisinfectionPseudomonas aeruginosaStaphylococcus aureusSurface PropertiesDisinfectantsDisinfectant efficacy testingDry surface biofilmsPseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID32807240
PMCPMC7430009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.